Surgery Techniques for Cervical Spondylosis
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Dorsal Decompression with Fusion, Dorsal Laminoplasty, and Ventral decompression with Fusion for Cervical Spondylosis?
Research shows that both dorsal and ventral decompression techniques, including laminoplasty and anterior discectomy, are effective for treating cervical spondylosis, with many patients experiencing improvement. However, the choice of technique should be tailored to the patient's specific condition to achieve the best outcomes.12345
Is surgery for cervical spondylosis generally safe?
Surgery for cervical spondylosis, including both ventral (front) and dorsal (back) decompression and fusion techniques, is generally considered safe, but it does have some risks. Complication rates for ventral fusion range from 11% to 13.6%, while dorsal fusion has slightly higher rates, from 16.4% to 19%. Minimally invasive techniques aim to reduce these risks and postoperative pain.12467
How does the treatment 'Dorsal Decompression with Fusion, Dorsal Laminoplasty, Ventral Decompression with Fusion' differ from other treatments for cervical spondylosis?
This treatment is unique because it combines both dorsal (back) and ventral (front) surgical approaches to relieve pressure on the spinal cord and nerves, potentially reducing complications like postoperative kyphosis (forward bending of the spine) and improving neurological function. The use of minimally invasive techniques in dorsal procedures aims to minimize disruption to the neck's supporting structures, which may lead to less pain and fewer deformities after surgery.128910
What is the purpose of this trial?
The purpose of the study is to determine the optimal surgical approach (ventral vs dorsal) for patients with multi-level cervical spondylotic myelopathy (CSM). There are no established guidelines for the management of patients with CSM, which represents the most common cause of spinal cord injury and dysfunction in the US and in the world.This study aims to test the hypothesis that ventral surgery is associated with superior Short Form-36 physical component Score (SF-36 PCS) outcome at one year follow-up compared to dorsal approaches and that both ventral and dorsal surgery improve symptoms of spinal cord dysfunction measured using the modified Japanese Orthopedic Association Score (mJOA). A secondary hypothesis is that health resource utilization for ventral surgery, dorsal fusion, and laminoplasty surgery are different. A third hypothesis is that cervical sagittal balance post-operatively is a significant predictor of SF-36 PCS outcome.
Research Team
Zoher Ghogawala, MD
Principal Investigator
Lahey Clinic, Inc.
Eligibility Criteria
This trial is for adults with cervical spondylotic myelopathy, which means they have spinal cord compression at multiple levels from C3 to C7 and symptoms like clumsy hands or walking problems. They shouldn't have had previous neck surgery or certain spine deformities, and must be healthy enough for anesthesia.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative
Pre-operative imaging and assessments including cervical MRI, CT, and x-rays
Treatment
Participants undergo either ventral or dorsal surgical approach for decompression/fusion
Post-operative Follow-up
Functional outcomes assessed using SF-36, Oswestry NDI, and EuroQol-5D at 3 months, 6 months, and 1 year
Long-term Follow-up
Annual assessments of functional outcomes and health resource utilization up to 5 years
Treatment Details
Interventions
- Dorsal (Back) Decompression with Fusion
- Dorsal (back) Laminoplasty
- Ventral (Front) decompression with Fusion
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lahey Clinic
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator